We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

BIOSYNEX

Biosynex designs, manufactures and distributes Rapid Diagnostic Tests (RDTs) which, in their professional version, al... read more Featured Products: More products

Download Mobile App




Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care

By LabMedica International staff writers
Posted on 10 Apr 2023
Print article
Image: LabPad Evolution is a handheld PoC multi-measurements testing device (Photo courtesy of Biosynex)
Image: LabPad Evolution is a handheld PoC multi-measurements testing device (Photo courtesy of Biosynex)

A multi-technology, multi-parameters Point of Care (PoC) device combines two technologies in a single device for a unique evolutive panel of tests. The pocket-sized lab can perform multiple biological analyses from just a finger prick of blood and send the results via Bluetooth to a smartphone or tablet.

LabPad Evolution from Biosynex SA (Illkirch-Graffenstaden, France) is a handheld PoC device that healthcare professionals can use to perform multiple lab-quality measurements directly with patients. With its miniature automated microscope built from two CMOS sensors, the LabPad Evolution can carry out blood tests from a single finger prick. The device uses compatible single-use SmartChip tests that are available in two formats: Tsmart and Ksmart, each for different types of testing. Tsmart is intended for coagulation testing as INR, consisting of a microfluidic microcuvette embedding a dried or freeze-dried reagent (dry chemistry) while Ksmart is meant for lateral flow testing based on visual or fluorescent optical measurements. The LabPad Evolution automatically conducts internal quality controls before, during, and after each measurement, and displays an error message if any interference is detected.

LabPad Evolution can operate as a standalone tool, storing up to 1,000 results in its memory, which can be viewed on its screen. Additionally, the LabPad Evolution is fully connected and can transmit results automatically via USB or Bluetooth. It can integrate with information systems for centralized processes such as operator authorization/identification, patient identification, quality controls, and results validation/management. The current available SmartChip tests are for SARS-COV-2 Antigen, SARS-COV-2 Antibody, and TP/INR rapid tests. Future tests will focus on nutrition and cardiac markers.

Related Links:
Biosynex SA

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.